# Phase 2B Closeout

## Human acceptance record

- **Project:** WebMCP Research Workbench
- **Phase:** Phase 2B — Shared Evidence Mission
- **Decision:** HUMAN ACCEPTED / PASS
- **Acceptance date:** 2026-08-27
- **Canonical pre-Phase-2B main:** `b310573f81f4e74806c0ba639d31a7c9a1906d50`
- **Validated deployed implementation:** `3d58354795465862dd61b618f2f740a0b58e06b8`
- **Phase 2B reviewed branch HEAD before closeout:** `63abdd849fe21ee1394b24418204948823362a9b`
- **PR:** #3
- **Production alias:** <https://webmcp-research-workbench.vercel.app/>
- **Deployment ID:** `dpl_7JSNudHRnPAVkPKwGyFZaMFYEuAT`
- **Deployment evidence:** `docs/15-phase-2b-deployment-validation.md`
- **Independent discriminator:** READY_TO_ACCEPT
- **BLOCKER:** None
- **MATERIAL:** None

## Accepted PASS basis

Phase 2B demonstrated:

- persistent human-defined research mission;
- shared UI/WebMCP workspace state;
- exactly five WebMCP tools;
- real OpenAlex keyword search;
- real OpenAlex-hosted semantic search;
- enriched source details;
- agent evidence proposal staging;
- human-only evidence acceptance/rejection;
- canonical provider resolution before proposal mutation;
- accepted-evidence-only atomic brief drafting;
- human edit/review/approval;
- refresh persistence;
- bounded activity ledger;
- inert provider/agent content;
- no DOM actuation;
- Phase 2A behavior preserved;
- tests/lint/build PASS; and
- public production validation PASS.

## Accepted MINOR findings

1. Strict malformed enrichment fields can fail one details request instead of degrading individual fields to unknown/null.
2. Duplicate/over-cap proposal batches may resolve provider records before final capacity/dedup rejection.
3. Semantic dispatch throttling is process-instance-local in distributed serverless deployment.
4. Production Reset was deterministic-test validated but not destructively exercised in the production browser.
5. Minor redundant proposal validation exists across the WebMCP/domain boundary.

These findings are accepted as non-gating Phase 2B limitations. Do not fix them during closeout.

## Phase boundary

Phase 2B acceptance does NOT authorize additional product implementation.

Phase 3 — Challenge Readiness / Submission requires a separate explicit human authorization.
